Literature DB >> 21146659

The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality.

Amit P Amin1, John A Spertus, Kimberly J Reid, Xiao Lan, Donna M Buchanan, Carole Decker, Frederick A Masoudi.   

Abstract

BACKGROUND: Although an acute worsening in renal function (WRF) commonly occurs among patients hospitalized for acute myocardial infarction (AMI), its long-term prognostic significance is unknown. We examined predictors of WRF and its association with 4-year mortality.
METHODS: Acute myocardial infarction patients from the multicenter PREMIER study (N=2,098) who survived to hospital discharge were followed for at least 4 years. Worsening in renal function was defined as an increase in creatinine during hospitalization of ≥0.3 mg/dL above the admission value. Correlates of WRF were determined with multivariable logistic regression models and used, along with other important clinical covariates, in Cox proportional hazards models to define the independent association between WRF and mortality.
RESULTS: Worsening in renal function was observed in 393 (18.7%) of AMI survivors. Diabetes, left ventricular systolic dysfunction, and a history of chronic kidney disease (documented history of renal failure with baseline creatinine>2.5 mg/dL) were independently associated with WRF. During 4-year follow-up, 386 (18.6%) patients died. Mortality was significantly higher in the WRF group (36.6% vs 14.4% in those without WRF, P<.001). After adjusting for other factors associated with WRF and long-term mortality, including baseline creatinine, WRF was independently associated with a higher risk of death (hazard ratio=1.64, 95% CI 1.23-2.19).
CONCLUSIONS: Worsening in renal function occurs in approximately 1 of 6 AMI survivors and is independently associated with an adverse long-term prognosis. Further studies on interventions to minimize WRF or to more aggressively treat patients developing WRF should be tested.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146659     DOI: 10.1016/j.ahj.2010.08.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  49 in total

1.  Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study.

Authors:  Spyridon Liosis; Timm Bauer; Rudolf Schiele; Helmut Gohlke; Martin Gottwik; Hugo Katus; Georg Sabin; Ralf Zahn; Steffen Schneider; Bernhard Rauch; Jochen Senges; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2013-06-06       Impact factor: 5.460

2.  Serum Uric Acid Levels and Renal Impairment among ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Intervention.

Authors:  Yacov Shacham; Amir Gal-Oz; Nir Flint; Gad Keren; Yaron Arbel
Journal:  Cardiorenal Med       Date:  2016-02-25       Impact factor: 2.041

3.  Influence of chronic kidney disease and worsening renal function on clinical outcomes in patients undergoing primary percutaneous coronary intervention.

Authors:  Toshijiro Aoki; Hideki Ishii; Akihito Tanaka; Susumu Suzuki; Satoshi Ichimiya; Masaaki Kanashiro; Toyoaki Murohara
Journal:  Clin Exp Nephrol       Date:  2018-09-14       Impact factor: 2.801

Review 4.  The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Giorgio Vescovo; Antonio Granata; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2014-05-14       Impact factor: 2.041

Review 5.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

6.  The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.

Authors:  James B Wetmore; Fengming Tang; Abhinav Sharma; Philip G Jones; John A Spertus
Journal:  Am Heart J       Date:  2015-07-26       Impact factor: 4.749

7.  Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study.

Authors:  Yacov Shacham; Eran Leshem-Rubinow; Arie Steinvil; Eyal Ben Assa; Gad Keren; Arie Roth; Yaron Arbel
Journal:  Clin Res Cardiol       Date:  2014-02-13       Impact factor: 5.460

8.  Cardiovascular morbidity and long term mortality associated with in hospital small increases of serum creatinine.

Authors:  Attilio Losito; Emidio Nunzi; Loretta Pittavini; Ivano Zampi; Elena Zampi
Journal:  J Nephrol       Date:  2017-05-31       Impact factor: 3.902

9.  High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.

Authors:  Yacov Shacham; Eran Leshem-Rubinow; Arie Steinvil; Gad Keren; Arie Roth; Yaron Arbel
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

10.  A Single-Centre Study of Acute Cardiorenal Syndrome: Incidence, Risk Factors and Consequences.

Authors:  Zehra Eren; Olcay Ozveren; Elif Buvukoner; Elif Kaspar; Muzaffer Degertekin; Gulcin Kantarci
Journal:  Cardiorenal Med       Date:  2012-04-27       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.